Sachet A Shukla Selected Research

Sachet A Shukla Research Topics

Disease

35	Neoplasms (Cancer) 03/2024 - 07/2012
11	Melanoma (Melanoma, Malignant) 01/2022 - 10/2015
8	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 01/2019
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2012
3	Carcinoma (Carcinomatosis) 01/2021 - 03/2016
2	Triple Negative Breast Neoplasms 12/2022 - 01/2022
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 08/2014
2	Tics (Tic) 01/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 04/2016
2	Endometrial Neoplasms (Endometrial Cancer) 02/2017 - 12/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Residual Neoplasm 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2016
1	Testicular Neoplasms (Testicular Cancer) 01/2016
1	Glioma (Gliomas) 12/2014
1	Ewing Sarcoma (Sarcoma, Ewing) 11/2014
1	Leukemia 07/2014
1	Cardiomyopathies (Cardiomyopathy) 02/2011

Drug/Important Bio-Agent (IBA)

15	Immune Checkpoint InhibitorsIBA 03/2024 - 12/2015
7	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2012
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2012
5	NivolumabIBA 01/2022 - 01/2019
5	VaccinesIBA 01/2021 - 01/2017
4	EpitopesIBA 01/2022 - 01/2019
4	Peptides (Polypeptides)IBA 01/2022 - 07/2014
4	AntigensIBA 01/2022 - 01/2016
4	MicroRNAs (MicroRNA)IBA 10/2017 - 07/2012
3	Everolimus FDA Link 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 10/2017 - 08/2012
1	atezolizumabIBA 01/2022
1	avelumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	Axitinib (AG 013736)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Estrogen ReceptorsIBA 01/2021
1	PlatinumIBA 01/2021
1	Protein Subunit VaccinesIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Sucrose (Saccharose)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Tumor Viral Antigens (Large T Antigen)IBA 11/2018
1	LigandsIBA 01/2018
1	Ligases (Synthetase)IBA 01/2018
1	UbiquitinIBA 01/2018
1	Histocompatibility Antigens Class IIBA 10/2017
1	Long Noncoding RNAIBA 10/2017
1	Calcibiotic Root Canal SealerIBA 04/2016
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2016
1	Amino Acids FDA Link 01/2016
1	IpilimumabIBA 10/2015
1	Monoclonal AntibodiesIBA 10/2015
1	AntagomirsIBA 12/2014
1	Transcription Factors (Transcription Factor)IBA 11/2014
1	DNA (Deoxyribonucleic Acid)IBA 08/2014
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 07/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2011

Therapy/Procedure

9	Therapeutics 03/2024 - 10/2015
9	Immunotherapy 03/2024 - 12/2015
2	Aftercare (After-Treatment) 01/2022 - 01/2021
2	Radiotherapy 01/2019 - 12/2014
1	Drug Therapy (Chemotherapy) 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2020